Subscribe

Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020

Publisher : Grace Market Data | SKU : 92000008 | Pages : 85 |
Published Date : 2015-05-08 | Region : Global | Country : NA | Category: Pharma & Healthcare

Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020

Grace Market Data | SKU : 92000008
Pages : 85 | May, 15 | Region : Global
Figures : NULL | Tables : NULL
Category: Pharma & Healthcare
NA

The global medical devices (MD) market represents a steady growing industrial sector as well as an attractive investment opportunity for profitable rewards. However, the potential for greater investment return may be constrained by a number of barriers and risks in global medical device market — most notably, maturing industry growth stage, challenging and changing regulatory laws and procedures, and declining profit margins. Hence, in-depth information and enhanced strategic intelligence are needed to minimize the potential risks associated with new entrants into the global medical device industry.

This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (arising from the surrounding environments) in global medical devices industry and market. The major internal risks recognized in this industry include industry growth stage, industry competition pressure, market entry barriers, industry volatility, and technology challenge. The major external risks include factors like profit decline, regulation force, effect of foreign direct investment, and other risks (namely shortage of upstream supply, competition from substitutes, and purchase potential decrease).

The risk evaluation and threat rating concentrate on worldwide medical device market under the industry conditions and environments in 2014. Forecasts and projections have been performed for the trend of industry risk over the next six years (2014-2020). All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). These in-depth appraisals and analysis about risk considerations & controls provide a comprehensive understanding of the current risk factors and likelihood of risk development trends. Moreover, this report also provides wise risk management strategies and concludes Critical Success Factors (CSFs) to help identify fresh growth point and overcome the threats and obstacles of doing manufacture/business in global medical device industry.

  • CHAPTER I. INTRODUCTION
  • I-1. Report Scope
  • I-2. Evaluation Methodology
  • I-3. Executive Summary
  • CHAPTER II. INTERNAL RISK
  • II-1. Overview of Internal Risk 2014-2020
  • II-2. Industry Growth Stage 2014-2020
  • II-3. Industry Competition Pressure 2014-2020
  • II-4. Market Entry Barriers 2014-2020
  • II-5. Industry Volatility 2014-2020
  • II-6. Technology Challenge 2014-2020
  • CHAPTER III. EXTERNAL RISK
  • III-1. Overview of External Risk 2014-2020
  • III-2. Profit Decline 2014-2020
  • III-3. Regulation Force 2014-2020
  • III-4. Foreign Direct Investment (FDI) 2014-2020
  • III-5. Other Risks 2014-2020
  • CHAPTER IV. SUMMARY AND FORCAST
  • IV-1. Summary of Medical Device Industry Risk in 2014
  • IV-2. Forecast of Medical Device Industry Risk to 2020
  • CHAPTER V. CRITICAL SUCCESS FACTORS (CSFs)
  • CHAPTER VI. RELATED REPORTS

Figure 1. GMD RIN of Internal Risk Factors in 2014 on Radar Chart
Figure 2. GMD RIN of Industry Growth Stage in 2014 and 2020
Figure 3. GMD RIN of Industry Competition Pressure 2014 and 2020
Figure 4. GMD RIN of Market Entry Barriers in 2014 and 2020
Figure 5. GMD RIN of Industry Volatility in 2014 and 2020
Figure 6. GMD RIN of Technology Challenge in 2014 and 2020
Figure 7. Global R&D Spend in Medical Devices 2004-2020
Figure 8. GMD RIN of External Risk Factors in 2014 on Radar Chart
Figure 9. GMD RIN of Profit Decline 2014 and 2020
Figure 10. GMD RIN of Regulation Force in 2014 and 2020
Figure 11. Maximum Approval Time of Medical Devices in Various Major Markets in 2014
Figure 12. GMD RIN of Foreign Direct Investment 2014-2020
Figure 13. Total Value and Number of Global FDI Projects in Medical Device Sector 2004-2014
Figure 14. Global Share of Inward FDI into the Medical Devices Sector by Subsectors, 2003-Jan 2014
Figure 15. Global Share of Inward FDI into the MD by Business Activity, 2003-JAN 2014
Figure 16. GMD RIN of Other Risks in 2014 and 2020
Figure 17. Total Health Expenditure as a Percentage of GDP for Major Economies (2013)
Figure 18. Comparison of Risk Factors by Weighted RIN in 2014
Figure 19. Comparison of Risk Factors by Predicted Weighted RIN in 2020

Table 1. List of Risk Factors and Weight Percentages
Table 2. Definition of GMD Risk Index Number (RIN) and GMD Risk Intensity Level (RIL)
Table 3. Overall Risk Index Numbers of Global Medical Device Industry 2014-2020
Table 4. Overview of Internal Risk 2014-2020
Table 5. Quarterly IPO Count and Value in Worldwide Medical Device Sector 2013Q1-2014Q2
Table 6. Count and Value of Venture Capital Investment (VCI) in Worldwide Medical Device Sector 2009-2014H1
Table 7. Top 30 Global MD Manufacturers Based on 2012 Revenue
Table 8. Top 40 Medical Device Producers Based on Annual Revenue in 2014
Table 9. Medical Device Exports of Leading Sourcing Countries 2012-2020 ($ bn)
Table 10. Slowdown of Global Medical Device Industry 2009-2020 ($ bn)
Table 11. Relative Innovation Level of Medtech by Country 2014
Table 12. Leading Companies in Medical Device R&D Spend by 2020
Table 13. Overview of External Risk 2014-2020
Table 14. Top Source Markets for FDI in Medical Device Sector, 2003-Jan 2014
Table 15. Top Destination Markets for FDI in MD Sector, 2003-Jan 2014
Table 16. Top Ten Investing Companies in MD Sector, 2003-Jan 2014
Table 17. Per Capita Total Expenditure on Health at Average Exchange Rate by Country 2003-2012 (US$)
Table 18. Summary of Risk Evaluation in 2014
Table 19. Summary of Risk Outlook in 2020
Table 20. List of Critical Success Factors

Single User LicenseHard CopySite LicenseGlobal License
Users/ Sharing Restricted to 10 Authorized Users Unlimited within the Geography Unlimited within the Geography Unlimited within any geography
Delivery Formats
Content Citation
Printing/Copy Unlimited within Company / Enterprise Unlimited within Company / Enterprise
10% Pre-sale customization
16 Hours post sales support
Free report on update within 100 days from purchase date

Bonafide Research & Marketing shall grant the user a worldwide, non-exclusive, non-transferable license. User can opt for -

Single User License (Electronic):Access to the content will be granted to 10 authorized users within the organization. The Authorized User may store, display or archive the information but is not allowed to print, copy or use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. The report will be emailed to you in PDF format.

Enterprise wide (Hard Copy):Access to the content will be granted to all authorized users within the organization. The individual user will treat the information in the report as confidential and will only use this for internal purpose. Please add $250 when purchasing the Report in order to get the printed version.

Site License (Electronic):Access to the content will be granted to all the authorised within the organization. The users are authorized to store, display, duplicate, archive the information within the organization either electronically or printable files. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose.

Enterprise Wide License (Electronic):The report will be emailed to you in PDF format and hard copy format. This is an enterprise license, allowing all employees within your organization access to the product. The company can use the data / information externally but they need to mention source as Bonafide Research

Whether a single user or a multi user, you are not permitted to -

  • Transmit by any means, or permit any third party to use and/or gain access to an electronic copy of the Product;
  • Resell, sub-license, rent, lease, transfer or attempt to assign the rights in the Product (in whole or in part) to any third party;
  • Modify or alter the Product or create a database in electronic or structured manual form by systematically downloading and storing any of the content from such Product other than for internal business purposes;
  • Download, store, reproduce, transmit, display, copy, distribute, commercially exploit or use the Product other than as expressly permitted above; and use the Product in any manner that would contravene the T&Cs contained in these License Terms or that would contravene law in any other jurisdiction.

Impactful Insights

Every project that comes through our doors gets senior-level attention at every step of the way. Our insights drive intelligent and informed decision-making and this is why our clients come back to us when it's time for the next project.

  • Bonafide Research's market reports are a combination of primary interviews of industry experts, traders, distributors, consumers as well as secondary inputs from company financials, press releases, associations, trade journals, paid databases, government sources etc.
  • We collect up-to-date and accurate information by conducting online surveys and exhaustive personal interviews to extract maximum information possible.
  • Application of critical analysis is done to cut through the hype and get the truth behind it.
  • Bonafide Research also carries dealer-distributor research surveys which are conducted with suppliers, manufacturers, whole-sellers, retailers and distributors to extract the authentic market data.
  • We scrutinize various published documents from different key sources in order to validate the data gaps and verify the information being collected through primary research surveys.
  • Fitting strategic recommendations are provided.

Outlook and Overview Reports!!

  • Outlookreports gives an in-depth understanding of the market
  • Overviewreports are published mainly for the price conscious clients.

Superior service:

  • Pre sales 10% customization, 16 Hours Post sales support
  • Updated version within 100 days from your purchase?? Get the free!!!

Simplified Pricing Strategy:

  • Single User + $250 = Hard copy
  • Hard Copy+ $250 = Site license
  • Site license + $700 = Global License
  • Get Free Shipping on Hard Copies of the Report

Discounts & benefits!!!

  • First time buyers?? Check product page and avail up to 10%discount.This discount is automatically generated by system and is completely variable, independent of any bias.
  • Buy 2 reports in one transaction?? Get 20% off on the low price variant.
  • Buy 3 Reports, Get 50% Discount on the Third low price variant.
  • Existing clients, additional 5% discount over and above all discounts!!!

Related Products

2017 Top 5 Dunaliella Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa NA
Read More

2017 Top 5 Emergency Ambulance Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa NA
Read More

2017 Top 5 Ginseng Extract Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa NA
Read More

2017 Top 5 Injectable Anticoagulants Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa NA
Read More

2017-2022 Asia-Pacific Top Countries Dunaliella Market Report NA
Read More

2017-2022 Asia-Pacific Top Countries Emergency Ambulance Market Report NA
Read More

Compare 0